Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Inflammatory Bowel Diseases 2Crohn Disease 2Colitis, Ulcerative 2Lymphoma 1Kidney Transplantation 1Hematologic Neoplasms 1Granulomatous Disease, Chronic 1Graft vs Host Disease 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Bronchiolitis Obliterans Syndrome 1Bipolar Disorder 1

Interventions

Tacrolimus 1Sirolimus 1Infliximab 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Kidney Transplantation × Infliximab × Clear all
NCT02711202 2026-04-13

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

Institute for Clinical and Experimental Medicine

Phase NA Completed
20 enrolled 11 charts
Genitourinary

Kidney Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡